MGIM
BLFS icon

M&G Investment Management’s BioLife Solutions BLFS Stock Holding History

M&G Investment Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,348
Closed -$771 – 515
2021
Q3 		$771 Sell
18,348
-12,752
-41% -$614K ﹤0.01% 652
2021
Q2 		$1.4K Buy
+31,100
New +$1.1M ﹤0.01% 576

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

M&G Investment Management's BLFS Position: Q4 2021 in Review

M&G Investment Management sold out of BioLife Solutions (BLFS) in Q4 2021, closing a stake of 18,348 shares — an estimated $771 sold.

M&G Investment Management first reported a position in BLFS in Q2 2021 and held it in 2 quarters. The position peaked at $1.4K in Q2 2021. 169 funds tracked by Wall St. Rank hold BLFS as of Q4 2021.

  • M&G Investment Management reported no remaining BioLife Solutions position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 18,348 BioLife Solutions shares in Q4 2021, an estimated $771.
  • M&G Investment Management first reported a position in BioLife Solutions in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's BioLife Solutions position peaked at $1.4K in Q2 2021.
  • 169 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.